SARS-CoV-2 variants- Evolution, spike protein, and vaccines

被引：24

作者：

Chen, Kai-Wei K. ^{[1
]}

Huang, Daniel Tsung-Ning ^{[1
,2
]}

Huang, Li -Min ^{[3
,4
]}

机构：

[1] MacKay Childrens Hosp, Dept Pediat, Taipei, Taiwan

[2] MacKay Med Coll, Dept Med, Taipei, Taiwan

[3] Natl Taiwan Univ, Natl Taiwan Univ Childrens Hosp, Dept Pediat, Coll Med, Taipei, Taiwan

[4] Natl Taiwan Univ, Natl Taiwan Univ Childrens Hosp, Dept Pediat, Coll Med, 8 Zhongshan S Rd, Taipei, Taiwan

来源：

BIOMEDICAL JOURNAL | 2022年 / 45卷 / 04期

关键词：

COVID-19; SARS-CoV-2; Spike mutations; Variant of concern; Vaccines; RECEPTOR-BINDING DOMAIN; CHADOX1; NCOV-19; COVID-19; MUTATIONS; BNT162B2; B.1.1.7; BOOST; P.1;

D O I：

10.1016/j.bj.2022.04.006

中图分类号：

Q5 [生物化学]; Q7 [分子生物学];

学科分类号：

071010 ; 081704 ;

摘要：

Despite the rising natural and vaccines mediated immunity, several countries have experienced a resurgence of the Coronavirus disease of 2019 (COVID-19) due to the emergence of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) variants. From Alpha to Omicron, the variants of concern (VOC) have evolved several spike protein mutations that may have an impact on virus characteristics, such as transmissibility and antigenicity. In this review, we describe the evolution of SARS-CoV-2, summarize current knowledge of epidemiological and clinical features of the variants, and discuss the response strategies in terms of vaccines to reduce the burden of COVID-19.

引用

页码：573 / 579

页数：7

共 50 条

[1] Mutations and Evolution of the SARS-CoV-2 Spike Protein
Magazine, Nicholas
Zhang, Tianyi
Wu, Yingying
McGee, Michael C.
Veggiani, Gianluca
Huang, Weishan
[J]. VIRUSES-BASEL, 2022, 14 (03):
[2] SARS-CoV-2 Variants and Vaccines
Krause, Philip R.
Fleming, Thomas R.
Longini, Ira M.
Peto, Richard
Briand, Sylvie
Heymann, David L.
Beral, Valerie
Snape, Matthew D.
Rees, Helen
Ropero, Alba-Maria
Balicer, Ran D.
Cramer, Jakob P.
Munoz-Fontela, Cesar
Gruber, Marion
Gaspar, Rogerio
Singh, Jerome A.
Subbarao, Kanta
Van Kerkhove, Maria D.
Swaminathan, Soumya
Ryan, Michael J.
Henao-Restrepo, Ana-Maria
[J]. NEW ENGLAND JOURNAL OF MEDICINE, 2021, 385 (02): : 179 - 186
[3] SARS-CoV-2 SPIKE PROTEIN: an optimal immunological target for vaccines
Salvatori, Giovanni
Luberto, Laura
Maffei, Mariano
Aurisicchio, Luigi
Roscilli, Giuseppe
Palombo, Fabio
Marra, Emanuele
[J]. JOURNAL OF TRANSLATIONAL MEDICINE, 2020, 18 (01)
[4] SARS-CoV-2 spike protein: pathogenesis, vaccines, and potential therapies
Almehdi, Ahmed M.
Khoder, Ghalia
Alchakee, Aminah S.
Alsayyid, Azizeh T.
Sarg, Nadin H.
Soliman, Sameh S. M.
[J]. INFECTION, 2021, 49 (05) : 855 - 876
[5] SARS-CoV-2 spike protein: pathogenesis, vaccines, and potential therapies
Ahmed M. Almehdi
Ghalia Khoder
Aminah S. Alchakee
Azizeh T. Alsayyid
Nadin H. Sarg
Sameh S. M. Soliman
[J]. Infection, 2021, 49 : 855 - 876
[6] SARS-CoV-2 SPIKE PROTEIN: an optimal immunological target for vaccines
Giovanni Salvatori
Laura Luberto
Mariano Maffei
Luigi Aurisicchio
Giuseppe Roscilli
Fabio Palombo
Emanuele Marra
[J]. Journal of Translational Medicine, 18
[7] Evolution of the SARS-CoV-2 spike protein in the human host
Wrobel, Antoni G.
Benton, Donald J.
Roustan, Chloe
Borg, Annabel
Hussain, Saira
Martin, Stephen R.
Rosenthal, Peter B.
Skehel, John J.
Gamblin, Steven J.
[J]. NATURE COMMUNICATIONS, 2022, 13 (01)
[8] Evolution of the SARS-CoV-2 spike protein in the human host
Antoni G. Wrobel
Donald J. Benton
Chloë Roustan
Annabel Borg
Saira Hussain
Stephen R. Martin
Peter B. Rosenthal
John J. Skehel
Steven J. Gamblin
[J]. Nature Communications, 13
[9] The variants of SARS-CoV-2 and the challenges of vaccines
Han, Xiucui
Ye, Qing
[J]. JOURNAL OF MEDICAL VIROLOGY, 2022, 94 (04) : 1366 - 1372
[10] SARS-CoV-2 Vaccines Based on the Spike Glycoprotein and Implications of New Viral Variants
Martinez-Flores, Daniel
Zepeda-Cervantes, Jesus
Cruz-Resendiz, Adolfo
Aguirre-Sampieri, Sergio
Sampieri, Alicia
Vaca, Luis
[J]. FRONTIERS IN IMMUNOLOGY, 2021, 12

← 1 2 3 4 5 →